Health System

Biotech (3 of …)

A section of The Report on life sciences focusing on the biotechnology sector. Oh, just a reminder: the material posted about life science is a draft. More editing will occur before it’s in final form. I welcome your input.

Read More »

Big Pharma (2 of…)

Geez, I’m kind of overwhelmed by all the data for The Report. The life science sector is so big and complex. There’s no end to the information. I’ve had to say, “Enough!” to myself just to get started. Also the importance of the market-driven sector in cancer management keeps growing in my mind. I think this is key to anyone ...

Read More »

Health literacy (or is it ill-literacy?)

The Institute of Medicine (the folks who brought you the report a few years ago about all the accidents and mistakes being made in health care settings) is about to publish a new report entitled: Health Literacy: A Prescription to End Confusion. Basically, they’ve found that in the US there is a high level of illiteracy about health matters, so ...

Read More »

Molecular Medicine: Send in the lawyers (3 of 3)

One of the most interesting aspects of this conference on molecular medicine was a couple of sessions about intellectual property (IP). IP is the mother’s milk of the life science industry. What they have that is really of value is what they know and know how to do. Those intangibles are the gold assets of the industry just as the ...

Read More »